newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress

ZURICH, SWITZERLAND – October 13, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today presented first in vivo proof-of-concept data and additional in